BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Empagliflozin
1
Effect of empagliflozin on fractional excretion of sodium in patients with cirrhosis and refractory ascites
10/27/2025 10:57:52 AM | Browse: 382 | Download: 817
2
Metabolic and hepatic effects of semaglutide and empagliflozin on metabolic dysfunction-associated steatotic liver disease mice
10/27/2025 10:57:49 AM | Browse: 347 | Download: 753
3
Characteristic dysbiosis in patients with type 2 diabetes and hyperuricemia, and the effect of empagliflozin on gut microbiota
2/28/2025 10:47:09 AM | Browse: 365 | Download: 1107
4
Comparative efficacy of sodium glucose cotransporter-2 inhibitors in the management of type 2 diabetes mellitus: A real-world experience
3/15/2024 9:49:53 AM | Browse: 300 | Download: 1313
5
Elucidating the cardioprotective mechanisms of sodium-glucose cotransporter-2 inhibitors beyond glycemic control
2/4/2024 10:57:41 AM | Browse: 778 | Download: 1803
6
Empagliflozin ameliorates diabetic cardiomyopathy probably via activating AMPK/PGC-1a and inhibiting the RhoA/ROCK pathway
12/14/2023 9:36:12 AM | Browse: 375 | Download: 1841
7
Sodium-glucose Cotransporter-2 Inhibitors induced euglycemic diabetic ketoacidosis: A meta summary of case reports
8/11/2023 11:04:23 AM | Browse: 565 | Download: 1741
8
Potential for sodium-glucose cotransporter-2 inhibitors in the management of metabolic syndrome: A systematic review and meta-analysis
11/24/2022 8:01:57 AM | Browse: 697 | Download: 1754
9
Sodium-glucose co-transporter 2 inhibitors induced euglycemic diabetic ketoacidosis within four days of initiation
3/15/2022 2:23:07 PM | Browse: 790 | Download: 1293
10
Cardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy
12/23/2021 6:10:00 AM | Browse: 854 | Download: 1337
11
Empagliflozin alleviates podocytopathy and enhances glomerular nephrin expression in db/db diabetic mice
12/13/2020 5:45:32 AM | Browse: 987 | Download: 3031
12
Role of sodium-glucose co-transporter-2 inhibitors in the management of heart failure in patients with diabetes mellitus
5/11/2020 9:58:04 AM | Browse: 1086 | Download: 2155
13
Bilateral gangrene of fingers in a patient on empagliflozin: First case report
2/18/2019 3:14:49 AM | Browse: 1446 | Download: 1900
14
Effects of glycaemic management on diabetic kidney disease
5/15/2017 10:13:33 AM | Browse: 1794 | Download: 2333
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.